OMEPRAZOLE

Product NDC
51655-023
11-digit product format
516550023
Labeler code
51655
Product ID
51655-023_30e7e098-a723-485d-928f-b13f51193b58
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
OMEPRAZOLE
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Labeler
Northwind Pharmaceuticals, LLC
Application
ANDA076048
Marketing category
ANDA
Marketing start
2015-02-05
Marketing end
0000-00-00
Substance
OMEPRAZOLE
Active strength
40 mg/1
Pharmacologic classes
Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51655-023-262026-01-05C16284748780-19d75b9d1-09e1-f424-e053-dadaa90a57ce2c40d64b-5e7b-4381-9ebf-df3a4bf0edfe
51655-023-262020-01-31C16284748780-19d75b9d1-09e1-f424-e053-dadaa90a57ce2c40d64b-5e7b-4381-9ebf-df3a4bf0edfe

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
OMEPRAZOLEACTIVE INGREDIENTKG60484QX9OMEPRAZOLE CAPSULE, DELAYED RELEASE [NORTHWIND PHARMACEUTICALS, LLC]1
OMEPRAZOLEACTIVE MOIETYKG60484QX9OMEPRAZOLE CAPSULE, DELAYED RELEASE [NORTHWIND PHARMACEUTICALS, LLC]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51655-023OMEPRAZOLE CAPSULE, DELAYED RELEASE [NORTHWIND PHARMACEUTICALS, LLC]1Legacy NDC20150325_2c40d64b-5e7b-4381-9ebf-df3a4bf0edfe.zip